John W Smither insider trades
Open-market stock purchases and sales by John W Smither, Unknown at NewAmsterdam Pharma Co NV, from SEC Form 4 filings since Jan 29, 2013.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -62%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 4, 2026 | NAMS NewAmsterdam Pharma Co NV | Sold | $40.5K |
| Aug 3, 2026 | MBX MBX Biosciences, Inc | Bought (not open market) | — |
| Aug 3, 2026 | MBX MBX Biosciences, Inc | Bought (not open market) | — |
| Jul 1, 2026 | GNLX GENELUX Corp | Sold | $34.9K |
| Jun 16, 2026 | GNLX GENELUX Corp | Bought (not open market) | — |
| Jun 16, 2026 | GNLX GENELUX Corp | Bought (not open market) | — |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co NV | Bought (not open market) | — |
Companies traded
- NAMS NewAmsterdam Pharma Co NV: 1 sale, last Sep 4, 2026
- MBX MBX Biosciences, Inc: other filings, last Aug 3, 2026
- GNLX GENELUX Corp: 1 buy, 2 sales, last Jul 1, 2026
- ARQT Arcutis Biotherapeutics, Inc: 13 sales, last Feb 13, 2024
- AMTI Applied Molecular Transport Inc: other filings, last Dec 27, 2023
- EFTR eFFECTOR Therapeutics, Inc: other filings, last Jun 22, 2023
- SNNA Sienna Biopharmaceuticals, Inc: other filings, last Jul 15, 2018
- AKAO Achaogen Inc: other filings, last Jun 5, 2018
- KYTH Kythera Biopharmaceuticals Inc: 38 sales, last Oct 1, 2015